Cytokinetics Inc
CYTK
Market Cap$7.01B
Close$
$-9.29
114.3% downside
Current Fair Value
114.3% downsideOvervalued by 114.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.01 Billion |
|---|---|
| Enterprise Value | $7.01 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.45 |
| Beta | 1.31 |
| Outstanding Shares | 104,576,087 |
| Avg 30 Day Volume | 1,329,827 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.31 |
|---|---|
| PEG | 3779.2 |
| Price to Sales | - |
| Price to Book Ratio | -16.2 |
| Enterprise Value to Revenue | 930.84 |
| Enterprise Value to EBIT | -14.13 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | -1.6 |
Revenue Sources
No data
ESG Score
No data
About Cytokinetics Inc
CEO: Robert Blum